Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD
Okamoto, M, Hayakawa, F, Miyata, Y, Watamoto, K, Emi, N, Abe, A, Kiyoi, H, Towatari, M, Naoe, TVolume:
21
Year:
2007
Language:
english
Pages:
8
DOI:
10.1038/sj.leu.2404547
File:
PDF, 281 KB
english, 2007